Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment

被引：0
|
作者：
Marzio E.E. Sabbioni
Hans Peter Siegrist
Marisa Bacchi
Jürg Bernhard
Monica Castiglione
Beat Thürlimann
Hervé Bonnefoi
Lucien Perey
Richard Herrmann
Aron Goldhirsch
Christoph Hürny
机构：
[1] University HospitalInselspital,Medical Division Lory
[2] Medizinisch-chemisches Labor,Haus
[3] IBCSG,Medical Department C
[4] Biometrics,Gynecology Department
[5] Ares-Serono International S.A.,Oncology Department
[6] Kantonsspital,Oncology Division
[7] University Hospital Geneva,undefined
[8] University Hospital Lausanne,undefined
[9] University Hospital Basel,undefined
[10] Bürgerspital,undefined
来源：
Breast Cancer Research and Treatment | 2000年 / 59卷
关键词：
breast cancer; cellular immunity; β; -microglobulin; sIL-2r; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The association of known prognostic factors with immune cell counts and β2-microglobulin and soluble IL-2 receptor (sIL-2r) serum levels as markers of activation of the immune system was investigated in breastcancer.
引用
收藏
页码：279 / 287
页数：8
相关论文
共 50 条
  • [31] Adjuvant therapy for early stage breast cancer
    Sledge, GW
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 51 - 54
  • [32] Prognostic factors of second primary contralateral breast cancer in early-stage breast cancer
    Li, Zheng
    Sergent, Fabrice
    Bolla, Michel
    Zhou, Yunfeng
    Gabelle-Flandin, Isabelle
    ONCOLOGY LETTERS, 2015, 9 (01) : 245 - 251
  • [33] Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer
    Sylvia A. Reyes
    Tari A. King
    Kezhen Fei
    Rebeca Franco
    Nina A. Bickell
    Annals of Surgical Oncology, 2016, 23 : 1537 - 1542
  • [34] Factors Affecting the Completion of Adjuvant Chemotherapy in Early-Stage Breast Cancer
    Reyes, Sylvia A.
    King, Tari A.
    Fei, Kezhen
    Franco, Rebeca
    Bickell, Nina A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (05) : 1537 - 1542
  • [35] Association of prognostic factors in breast cancer
    Cioffi, M
    Puca, GA
    Gazzerro, P
    Di Finizio, B
    Catalano, T
    Vietri, MT
    Di Macchia, C
    Migliaccio, A
    Molinari, AM
    22ND CONGRESS OF THE INTERNATIONAL ASSOCIATION FOR BREAST CANCER RESEARCH, 1999, : 231 - 234
  • [36] Evaluating the association between adjuvant chemotherapy and function-related adverse events among older patients with early stage breast cancer
    Mariano, Caroline
    Lund, Jennifer L.
    Hinton, Sharon Peacock
    Htoo, Phyo
    Muss, Hyman
    Reeder-Hayes, Katherine E.
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (04) : 242 - 248
  • [37] Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes
    Schvartsman, Gustavo
    Gutierrez-Barrera, Angelica M.
    Song, Juhee
    Ueno, Naoto T.
    Peterson, Susan K.
    Arun, Banu
    CANCER MEDICINE, 2017, 6 (11): : 2515 - 2522
  • [38] Association of IL-10 with tumor markers and prognostic factors in early breast cancer patients
    Llanes-Fernandez, L.
    Alvarez-Goyanes, R.
    Arango-Prado, MC.
    Alcocer-Gonzalez, JM.
    Escobar-Perez, X.
    Orozco-Lopez, M.
    Franco-Odio, S.
    Camacho-Rodriguez, R.
    Guerra-Yi, ME.
    Madrid-Marina, V.
    Tamez-Guerra, R.
    Rodriguez-Padilla, C.
    13TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, 2007, : 205 - +
  • [39] Optimal timing of adjuvant treatment in patients with early breast cancer
    Alkis, Necati
    Durnali, Ayse G.
    Arslan, Ulku Y.
    Kocer, Murat
    Onder, Fatih O.
    Tokluoglu, Saadet
    Celenkoglu, Gokhan
    Muallaoglu, Sadik
    Utkan, Gungor
    Ulas, Arife
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2011, 28 (04) : 1255 - 1259
  • [40] Adjuvant treatment of early breast cancer
    Dal Lago, L
    Bernard-Marty, C
    Piccart, MJ
    EJC SUPPLEMENTS, 2005, 3 (03): : 149 - 166
12345